Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction

Author： Zhou Luyi   Sun Wei-Lun   See Ronald E.  

Publisher： MDPI

E-ISSN： 1424-8247|4|6|804-821

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.4, Iss.6, 2011-06, pp. : 804-821

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NMDA Receptor Modulators in the Treatment of Drug Addiction

By Tomek Seven E.   LaCrosse Amber L.   Nemirovsky Natali E.   Olive M. Foster  

Pharmaceuticals, Vol. 6, Iss. 2, 2013-02 ,pp. : 251-268

MDPI

Access to resources Recommend Favorite

Protein Kinases as Drug Development Targets for Heart Disease Therapy

By Dhalla Naranjan S.   Müller Alison L.  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2111-2145

MDPI

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development

By Rao Praveen P. N.   Kabir Saad N.   Mohamed Tarek  

Pharmaceuticals, Vol. 3, Iss. 5, 2010-05 ,pp. : 1530-1549

MDPI

Access to resources Recommend Favorite

Receptor and Channel Heteromers as Pain Targets

By Berg Kelly A.   Patwardhan Amol M.   Akopian Armen N.  

Pharmaceuticals, Vol. 5, Iss. 3, 2012-02 ,pp. : 249-278

MDPI

Access to resources Recommend Favorite

Are AMPA Receptor Positive Allosteric Modulators Potential Pharmacotherapeutics for Addiction?

By Watterson Lucas R.   Olive M. Foster  

Pharmaceuticals, Vol. 7, Iss. 1, 2013-12 ,pp. : 29-45

MDPI

Access to resources Recommend Favorite